NOTE: This article was made possible by an unrestricted educational grant from Sanofi, which had no control over content.
0 of 15 questions completed
You have already completed the module before. Hence you can not start it again.
Module is loading…
You have to finish following quiz, to start this quiz:
Time has elapsed
Thank you, we will review your submission and notify you of your results via email.
1. Is there evidence that CGM can improve patient outcomes?
2. Is there evidence that the CGM learnings on CGM are sustained off CGM in type 1 diabetes?
3. Is there evidence that CGM learnings on CGM are sustained off CGM in type 2 diabetes?
4. In terms of reduction in hypoglycaemia, which statement is CORRECT?
5. What is the biggest challenge with current CGM?
6. When should a clinician ask for structured testing by the type 2 diabetes patient?
7. Why is it likely that patient self-testing is biased?
8. Which of the following statements is INCORRECT?
9. Which of the following statements regarding CGM is incorrect?
10. In the GOLD trial, after use of CGM in type 1 diabetic patients and during subsequent measurement after removal of the device, the number of severe hypoglycaemic events were not increased.
11. CGM has been shown to be a behaviour modification intervention for type 2 diabetes because its use achieved:
12. Calibration of the CGM device should be done:
13. On CGM, managing postprandial glucose becomes:
Case Study 1
Patient: 28-year-old female with cystic fibrosis (CFRD) post lung transplant in 2013
- Patient is a food critic and is “forced” to eat for a living
- Dislikes needles and hardly ever tests her blood glucose levels
- On prednisone 7.5mg daily as maintenance part of her immunosuppressive regimen
- HbA1c 7.3% on glargine 34U pre-breakfast
- She really does not want more injections but her HbA1c is not where it should be
- An AGP was undertaken to assess the periods in which she was having hyperglycaemia (hoping to document the expected postprandial rises and convince her to add a meal time insulin)
- It was also done to investigate for nocturnal hypoglycaemia related to qd glargine or adrenal insufficiency.
NOTE: The clinician should seek to always use CGM before insulinising a patient.
14. On the basis of the above daily patterns trace, what will you do?
Case Study 2
Patient: A 37-year-old female, working as an office cleaner
- Patient gets up really early to come to work. Her HbA1c was 7.7%.
- This is her CGM using the freestyle LibrePro.
15. What is the indicative insulin approach from the CGM trace?
View Expert Comment »
The patient was put on prandial insulin and given dietary education. Her results within 10 days of this therapy is shown below.